Credo Diagnostics Biomedical

Credo Diagnostics Biomedical is a Singapore-based company founded in 2011 that specializes in developing, manufacturing, and commercializing molecular diagnostic platforms for Point-of-Care (POC) use. The company focuses on creating innovative technologies that simplify and accelerate diagnostic processes while ensuring high accuracy and affordability. Their mission is to enhance healthcare by providing effective rapid molecular diagnostics that enable timely and precise diagnoses for both human and veterinary healthcare. The core product is the QubeMDx system, a nucleic acid-based diagnostic platform designed for rapid disease detection at the POC. Additionally, Credo Diagnostics Biomedical offers rapid flu test kits and diagnostic solutions tailored for both medical and veterinary professionals. The company serves a diverse range of customers, including healthcare providers, veterinary professionals, and healthcare facilities, aiming to improve diagnostic turnaround times and reduce costs globally. With a commitment to research and development, Credo Diagnostics Biomedical is dedicated to making reliable diagnostic technologies accessible worldwide.

• Employees 41
• Founded 2011